Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Fluid Therapy Market: By Fluid Type, By Application, By Fluid Administration, By End Users, and Geography
The Fluid Therapy Market size was valued at US$ 10,212 million in 2022 which is expected to grow at a CAGR of 6.2% from 2023-2029. Fluid Therapy is a type of therapy that includes inoculation of the crystalloid mixture into patients whose circulating blood volume is decreased. This therapy can also be used for treating dehydration to substitute the fluid loss from the body. This therapy helps to meet the fluid requirements for those patients who cannot take fluids orally. The increasing prevalence of infectious and chronic diseases such as cancer, gastrointestinal tract, nephrology, and diabetes and the increasing number of minor invasive surgeries are some primary factors that can boost the global fluid therapy market. Apart from this, an increase in health consciousness among individuals, and expansion in marketable pipelines can also accelerate the market in the future. Another factor that drives the fluid therapy market is the growing research and development in the pharmaceutical and biotechnological industries to come up with new treatment methods for certain diseases such as sepsis, hypovolemia, colic and shock, and the launch of novel services and products.
Moreover, technological advancement and an increase in healthcare expenditure can drive market growth. However, some factors such as the high purchasing cost of fluid therapy instruments, lack of technical skills, and lack of awareness about this therapy among the population can restrain the growth of the market. Another factor that can hinder the growth of the market is concern about plastic bags releasing toxic chemicals into the veins of the patient. Moreover, the usage of single-use disposable accessories and devices and the developing market are expected to produce lucrative opportunities for the global market.
Study Period
2024-2030Base Year
2023CAGR
6.2%Largest Market
North-AmericaFastest Growing Market
Asia Pacific
One of the major reasons for the growth of the global fluid therapy market is the growing number of minor invasive surgeries. Minor surgeries have a variety of advantages over open surgeries such as rapid recovery periods, fewer postoperative problems, and lower danger of infection at the surgical site. These surgeries are also called outpatient surgeries as the patient does not have to stay overnight in the medical centers. Minimal invasive surgeries are done for the colon, appendix, and lungs. Moreover, these surgeries are covered by medical insurance companies across the globe which makes them even more popular. Thus, the increasing number of minor invasive surgeries for cancer treatment can accelerate the demand for the fluid therapy market in the future.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 10,212 million |
Market CAGR |
6.2% |
By Fluid Type |
|
By Application |
|
By End User |
|
Download Free Sample Report
The fluid therapy market is projected to expand at a CAGR of 6.2% during the forecast period
Fresenius Kabi AG, Dechra Veterinary Products, LLC, DJ labs, B. Braun Melsungen AG, Baxter, Animalcare, ICU Medical Inc.
Asia Pacific is the fastest-growing region for fluid therapy market
1. Executive Summary |
2. Global Fluid Therapy Market Introduction |
2.1. Global Fluid Therapy Market - Taxonomy |
2.2. Global Fluid Therapy Market -Definitions |
2.2.1. Fluid Type |
2.2.2. Application |
2.2.3. Fluid Administration |
2.2.4. End User |
2.2.5. By Region |
3. Global Fluid Therapy Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Fluid Therapy Market Dynamic Factors - Impact Analysis |
3.6. Global Fluid Therapy Market - Competition Landscape |
3.7. Epidemiology |
4. Global Fluid Therapy Market Analysis, 2018-2022 and Forecast, 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Fluid Therapy Market, By Fluid Type, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1. Colloids |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Crystalloids |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Blood |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Blood Products |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Fluid Therapy Market, By Application, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.1. Urology and Nephrology |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Laparoscopy |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Gastroenterology |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Gynecology / Obstetrics |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Bronchoscopy |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Arthroscopy |
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Cardiology |
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Neurology |
6.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
6.9. Otoscopy |
6.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.9.3. Market Opportunity Analysis |
6.10. Dentistry |
6.10.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.10.3. Market Opportunity Analysis |
6.11. Others |
6.11.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.11.3. Market Opportunity Analysis |
7. Global Fluid Therapy Market, By Fluid Administration, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1. Oral |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Subcutaneous |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Intravenous |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Intraosseous |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Intraperitoneal |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Others |
7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global Fluid Therapy Market, By End User, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1. Hospitals |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Dialysis Centers |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Ambulatory Surgical Centers |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Other |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Fluid Therapy Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Fluid Therapy Market - Opportunity Analysis Index, By Fluid Type, ByFluid Administration, By Application, By End User, and Region, 2023-2029 |
10. North America Fluid Therapy Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.1. Fluid Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Colloids |
10.1.2. Crystalloids |
10.1.3. Blood |
10.1.4. BloodProducts |
10.1.5. Others |
10.2. Fluid Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Oral |
10.2.2. Subcutaneous |
10.2.3. Intravenous |
10.2.4. Intraosseous |
10.2.5. Intraperitoneal |
10.2.6. Others |
10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Urology and Nephrology |
10.3.2. Laparoscopy |
10.3.3. Gastroenterology |
10.3.4. Gynecology / Obstetrics |
10.3.5. Bronchoscopy |
10.3.6. Arthroscopy |
10.3.7. Cardiology |
10.3.8. Neurology |
10.3.9. Otoscopy |
10.3.10. Dentistry |
10.3.11. Other |
10.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Hospitals |
10.4.2. Dialysis Centers |
10.4.3. Ambulatory Surgical Centers |
10.4.4. Other |
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Fluid Therapy Market - Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2023-2029 |
10.7. North America Fluid Therapy Market Dynamics - Trends |
11. Europe Fluid Therapy Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.1. Fluid Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Colloids |
11.1.2. Crystalloids |
11.1.3. Blood |
11.1.4. BloodProducts |
11.1.5. Others |
11.2. Fluid Admiration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Oral |
11.2.2. Subcutaneous |
11.2.3. Intravenous |
11.2.4. Intraosseous |
11.2.5. Intraperitoneal |
11.2.6. Others |
11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Urology and Nephrology |
11.3.2. Laparoscopy |
11.3.3. Gastroenterology |
11.3.4. Gynecology / Obstetrics |
11.3.5. Bronchoscopy |
11.3.6. Arthroscopy |
11.3.7. Cardiology |
11.3.8. Neurology |
11.3.9. Otoscopy |
11.3.10. Dentistry |
11.3.11. Other |
11.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Hospitals |
11.4.2. Dialysis Centers |
11.4.3. Ambulatory Surgical Centers |
11.4.4. Other |
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Rest of Europe |
11.6. Europe Fluid Therapy Market - Opportunity Analysis Index, By Fluid Type, ByFluid Administration, By Application, By End User, and Country, 2023-2029 |
11.7. Europe Fluid Therapy Market Dynamics - Trends |
12. Asia-Pacific Fluid Therapy Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.1. Fluid Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Colloids |
12.1.2. Crystalloids |
12.1.3. Blood |
12.1.4. BloodProducts |
12.1.5. Others |
12.2. Fluid Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Oral |
12.2.2. Subcutaneous |
12.2.3. Intravenous |
12.2.4. Intraosseous |
12.2.5. Intraperitoneal |
12.2.6. Others |
12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Urology and Nephrology |
12.3.2. Laparoscopy |
12.3.3. Gastroenterology |
12.3.4. Gynecology / Obstetrics |
12.3.5. Bronchoscopy |
12.3.6. Arthroscopy |
12.3.7. Cardiology |
12.3.8. Neurology |
12.3.9. Otoscopy |
12.3.10. Dentistry |
12.3.11. Other |
12.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.4.1. Hospitals |
12.4.2. Dialysis Centers |
12.4.3. Ambulatory Surgical Centers |
12.4.4. Other |
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. Japan |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Fluid Therapy Market - Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2023-2029 |
12.7. Asia-Pacific Fluid Therapy Market Dynamics - Trends |
13. Latin America Fluid Therapy Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
13.1. Fluid Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Colloids |
13.1.2. Crystalloids |
13.1.3. Blood |
13.1.4. BloodProducts |
13.1.5. Others |
13.2. Fluid Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Oral |
13.2.2. Subcutaneous |
13.2.3. Intravenous |
13.2.4. Intraosseous |
13.2.5. Intraperitoneal |
13.2.6. Others |
13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Urology and Nephrology |
13.3.2. Laparoscopy |
13.3.3. Gastroenterology |
13.3.4. Gynecology / Obstetrics |
13.3.5. Bronchoscopy |
13.3.6. Arthroscopy |
13.3.7. Cardiology |
13.3.8. Neurology |
13.3.9. Otoscopy |
13.3.10. Dentistry |
13.3.11. Other |
13.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Hospitals |
13.4.2. Dialysis Centers |
13.4.3. Ambulatory Surgical Centers |
13.4.4. Other |
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Fluid Therapy Market - Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2023-2029 |
13.7. Latin America Fluid Therapy Market Dynamics - Trends |
14. Middle East and Africa Fluid Therapy Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
14.1. Fluid Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Colloids |
14.1.2. Crystalloids |
14.1.3. Blood |
14.1.4. BloodProducts |
14.1.5. Others |
14.2. Fluid Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Oral |
14.2.2. Subcutaneous |
14.2.3. Intravenous |
14.2.4. Intraosseous |
14.2.5. Intraperitoneal |
14.2.6. Others |
14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Urology and Nephrology |
14.3.2. Laparoscopy |
14.3.3. Gastroenterology |
14.3.4. Gynecology / Obstetrics |
14.3.5. Bronchoscopy |
14.3.6. Arthroscopy |
14.3.7. Cardiology |
14.3.8. Neurology |
14.3.9. Otoscopy |
14.3.10. Dentistry |
14.3.11. Other |
14.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Hospitals |
14.4.2. Dialysis Centers |
14.4.3. Ambulatory Surgical Centers |
14.4.4. Other |
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. South Africa |
14.5.3. Rest of MEA |
14.6. MEA Fluid Therapy Market- Opportunity Analysis Index, By Fluid Type, By Fluid Administration, By Application, By End User, and Country, 2023-2029 |
14.7. MEA Fluid Therapy Market Dynamics - Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Key Fluid Types, Key Developments, Strategies, and SWOT Analysis) |
15.2.1.1. Fresenius Kabi AG |
15.2.1.2. Dechra Veterinary Products, LLC |
15.2.1.3. DJ labs |
15.2.1.4. B. Braun Melsungen AG |
15.2.1.5. Baxter |
15.2.1.6. Animalcare |
15.2.1.7. ICU Medical Inc. |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Key Market Players